{
    "title": "U.S. appeals court revives Glaxo $235.5 mln verdict against Teva",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8799225/U-S-appeals-court-revives-GlaxoSmithKline-235-5-mln-verdict-against-Teva.html",
    "date": "2020-10-02",
    "keywords": [
        "heart",
        "teva",
        "coreg",
        "patent",
        "court",
        "verdict",
        "decision",
        "circuit",
        "glaxo",
        "failure",
        "judge",
        "jonathan",
        "stempel",
        "jury",
        "drug",
        "market",
        "case",
        "infringement",
        "liability",
        "label",
        "friday",
        "glaxosmithkline",
        "plc",
        "version",
        "washington",
        "dc",
        "evidence",
        "outcome",
        "approval",
        "chemical",
        "name",
        "hypertension",
        "dysfunction",
        "attack",
        "generic",
        "treatment",
        "food",
        "administration",
        "drugmaker",
        "profit",
        "district",
        "leonard",
        "stark",
        "pauline",
        "newman",
        "press",
        "product",
        "fda",
        "testimony",
        "tevas",
        "chief",
        "sharon",
        "prost",
        "congress",
        "desire",
        "marketplace",
        "majoritys",
        "purpose",
        "et",
        "al",
        "v",
        "reporting",
        "york",
        "editing",
        "nomiyama",
        "matthew",
        "lewis",
        "cynthia",
        "osterman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}